Krystal Biotech, Inc. (KRYS)
NASDAQ: KRYS · Real-Time Price · USD
303.06
+2.18 (0.72%)
At close: Nov 9, 2026, 4:00 PM EST
304.10
+1.04 (0.34%)
Pre-market: Nov 10, 2026, 8:31 AM EST

Revenue

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23
Product Revenue, Net
470.03M389.13M290.52M
Revenue (Total)
470.03M389.13M290.52M